Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MNOV
MNOV logo

MNOV News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MNOV News

MediciNova's SEANOBI Study Reaches 50% Enrollment Milestone

Jan 30 2026NASDAQ.COM

MediciNova Activates SEANOBI Study with 100 Patient Enrollments

Jan 29 2026Newsfilter

Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers

Dec 19 2025NASDAQ.COM

MediciNova Completes Enrollment of 100 Patients for OXTOX Study on Chemotherapy-Induced Neuropathy

Dec 18 2025Globenewswire

MediciNova Completes Enrollment of 100 Patients in Phase 2 OXTOX Study for Chemotherapy-Induced Neuropathy

Dec 18 2025Newsfilter

MediciNova Reports Patient Data from 234 in ALS Clinical Trial

Dec 08 2025Globenewswire

MediciNova Reports Patient Data from 234 in ALS Clinical Trial

Dec 08 2025Newsfilter

MediciNova Unveils Novel Mechanism for MN-001 Enhancing Cholesterol Efflux

Dec 01 2025Globenewswire

MNOV Events

No data

No data

MNOV Monitor News

No data

No data

MNOV Earnings Analysis

No Data

No Data

People Also Watch